Armas Pharmaceuticals COVID-19 Statement
MANALAPAN, N.J., March 16, 2020 /PRNewswire/ -- In our role as a U.S. Healthcare Provider, Armas Pharmaceuticals Inc. (Armas) is working diligently with our international partners during the current global health emergency.
Armas is taking steps to ensure that our products are consistently available in our supply channel to help any shortages caused by the current pandemic, COVID-19. We will also continue to closely monitor stocking levels at our logistics provider. In addition, Armas is in contact with our supply chain partners, group purchasing organizations, wholesalers and distributors to oversee where we can assist in providing our pharmaceutical products.
Currently, we do not expect any product disruptions. We will continue to provide the convenience, cost-savings, sustainability and consistency to our customers throughout this crisis.
About Armas Pharmaceuticals Inc.
Contact: Jenifer Arabia
SOURCE Armas Pharmaceuticals